FDA OKs First Treatment for Lambert-Eaton Myasthenic Syndrome FDA OKs First Treatment for Lambert-Eaton Myasthenic Syndrome

Amifampridine (Firdapse) is approved for adults with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder characterized by muscle weakness.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news